✦ LIBER ✦

A phase II study of metronomic paclitaxel/cyclophosphamide/capecitabine followed by 5-fluorouracil/epirubicin/cyclophosphamide as preoperative chemotherapy for triple-negative or low hormone receptor expressing/HER2-negative primary breast cancer

✍ Scribed by Masuda, N.; Higaki, K.; Takano, T.; Matsunami, N.; Morimoto, T.; Ohtani, S.; Mizutani, M.; Miyamoto, T.; Kuroi, K.; Ohno, S.; Morita, S.; Toi, M.

Book ID: 125344329
Publisher: Springer
Year: 2014
Tongue: English
Weight: 519 KB
Volume: 74
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2492-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study of weekly pacl

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

✍ Ando, Masashi; Yamauchi, Hideko; Aogi, Kenjiro; Shimizu, Satoru; Iwata, Hiroji; 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 296 KB

A multicenter randomized phase II study

A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients

✍ Jean-Yves Pierga; Suzette Delaloge; Marc Espié; Etienne Brain; Brigitte Sigal-Za 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 236 KB